Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · IEX Real-Time Price · USD
74.86
-0.08 (-0.11%)
At close: Jul 19, 2024, 4:00 PM
75.32
+0.46 (0.61%)
Pre-market: Jul 22, 2024, 5:44 AM EDT
Intra-Cellular Therapies Market Cap
Intra-Cellular Therapies has a market cap or net worth of $7.90 billion as of July 22, 2024. Its market cap has increased by 28.53% in one year.
Market Cap
7.90B
Enterprise Value
7.44B
1-Year Change
28.53%
Ranking
Category
Stock Price
$74.86
Market Cap Chart
Since January 7, 2014, Intra-Cellular Therapies's market cap has increased from $332.00M to $7.90B, an increase of 2,280.53%. That is a compound annual growth rate of 35.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 7.90B | 14.66% |
| Dec 29, 2023 | 6.89B | 37.53% |
| Dec 30, 2022 | 5.01B | 17.54% |
| Dec 31, 2021 | 4.26B | 67.27% |
| Dec 31, 2020 | 2.55B | 34.44% |
| Dec 31, 2019 | 1.90B | 204.19% |
| Dec 31, 2018 | 623.30M | -21.13% |
| Dec 29, 2017 | 790.30M | 21.04% |
| Dec 30, 2016 | 652.90M | -71.79% |
| Dec 31, 2015 | 2.31B | 345.98% |
| Dec 31, 2014 | 518.90M | 56.30% |
| Jan 7, 2014 | 332.00M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Rad Laboratories | 8.48B |
| Bio-Rad Laboratories | 8.33B |
| Chemed | 8.22B |
| Roivant Sciences | 8.13B |
| Lantheus Holdings | 8.10B |
| Cerevel Therapeutics Holdings | 7.82B |
| The Ensign Group | 7.71B |
| Ascendis Pharma | 7.65B |